Google launches DeepMind 2, a pharmaceutical hullabaloo

November 05, 2021

By Tristan Greene

Alphabet (the umbrella corp that owns Google and DeepMind) just launched Isomorphic Labs (IL). According to the new company’s blog, it’s “reimagining the entire drug discovery process from first principles with an AI-first approach.” In other words: The CEO of DeepMind, Demis Hassabis, is going to run a drug-discovery spinoff. Up front: This seems like a really good thing. DeepMind’s AlphaFold 2 has supposedly revolutionized how researchers study protein structures. And Hassabis is obviously pretty good at running a lab. But let’s just have a gander at the company’s blog, shall we? Here’s an interesting quote: At its most fundamental…

This story continues at The Next Web

Or just read more coverage about: Google

Source:: The Next Web


No comments

You must be logged in to post a comment.
To ensure attendees get the full benefit of an intimate technology expo,
we are only offering a limited number of passes.
Get My Pass Now!